Cancer Incidence in Multiple Sclerosis: A 35-Year Follow-Up
- 20 August 2004
- journal article
- Published by S. Karger AG in Neuroepidemiology
- Vol. 23 (5), 224-227
- https://doi.org/10.1159/000079947
Abstract
The risk of cancer among multiple sclerosis (MS) patients was evaluated emphasising cancers with a potentially infectious aetiology. Cancer incidence was estimated among incident MS patients in 1964–1993 (n = 1,597) in Finland. The cohort was followed up for cancer incidence through the Finnish Cancer Registry until 1999. A total of 85 cancer cases were diagnosed showing a standardised incidence ratio (SIR) of 1.0 (95% CI 0.8–1.2) for all cancers. The risk (SIR) of haematological tumours was 1.1 and that of central nervous system (CNS) tumours 1.3. The small excess risk of haematological malignancies is consistent with infectious aetiology, whereas the association between MS and CNS tumours may be due to misclassification.Keywords
This publication has 5 references indexed in Scilit:
- Immunosuppressive drugs and cancerToxicology, 2003
- Mechanisms of demyelination and tissue destruction in multiple sclerosisClinical Neurology and Neurosurgery, 2002
- Epstein-Barr Virus Antibodies and Risk of Multiple SclerosisJAMA, 2001
- Regional and Temporal Variation in the Incidence of Multiple Sclerosis in Finland 1979–1993Neuroepidemiology, 2000
- A genetic basis for familial aggregation in multiple sclerosisNature, 1995